NCT01924767
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- 1245.2.1 Boehringer Ingelheim Investigational Site Neuss, Germany
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
7,980 public trials
715 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT02002611
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Samsung Medical Center Seoul, South Korea
NCT01602913
- Conditions
- Depression, Postpartum, Depressive Disorder, Diabetes Mellitus, +11 more
- Locations
-
Not specified
Completed
Gut Microbiota in Obesity and Diabetes
NCT02180191
- Conditions
- Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +11 more
- Locations
-
- Department of Endocrinology and Metabolism, Gulhane School of Medicine Ankara, Turkey (Türkiye)
NCT01051674
- Conditions
- Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +11 more
- Locations
-
- Loma Linda U Medical Center Diabetes Treatment Center Loma Linda, California, United States
NCT00613782
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +6 more
- Locations
-
- Austin Health Melbourne, Victoria, Australia
NCT00108225
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- VA Medical Center, Minneapolis Minneapolis, Minnesota, United States
NCT01087502
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- 1218.64.10007 Boehringer Ingelheim Investigational Site Chula Vista, California, United States
- 1218.64.10018 Boehringer Ingelheim Investigational Site Pembroke Pines, Florida, United States
- 1218.64.10016 Boehringer Ingelheim Investigational Site Decatur, Georgia, United States
- 1218.64.10015 Boehringer Ingelheim Investigational Site Boise, Idaho, United States
Completed
Safety and Efficacy of Linagliptin (BI 1356) as Monotherapy or in Combination in Type 2 DM
NCT00736099
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- 1218.40.10003 Boehringer Ingelheim Investigational Site Chula Vista, California, United States
- 1218.40.10014 Boehringer Ingelheim Investigational Site Spring Valley, California, United States
- 1218.40.10001 Boehringer Ingelheim Investigational Site Walnut Creek, California, United States
- 1218.40.10021 Boehringer Ingelheim Investigational Site Northglenn, Colorado, United States
NCT00252525
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Carl T. Hayden VA Medical Center Phoenix, Arizona, United States
- VA Medical Center, Long Beach Long Beach, California, United States
- Miami VA Healthcare System, Miami, FL Miami, Florida, United States
- VA Medical Center, Omaha Omaha, Nebraska, United States